Showing 1571-1580 of 6984 results for "".
New Biologics
https://practicaldermatology.com/topics/psoriasis/new-biologics/18635/Craig Leonardi, MD, shares insight on developments in biologics that may offer significantly improved efficacy compared with existing agents. Dr. Leonardi also discusses the rapidly evolving treatment paradigm in the management of psoriasis.Camera Ready: How to Work with Media
https://practicaldermatology.com/topics/practice-management/camera-ready-how-to-work-with-media/18661/Hilary Baldwin, MD talks to host Neal Bhatia, MD about working with the media on this edition of Derm Insider. Her number one piece of advice: Make sure you know what you're doing and that you should be doing it, and know when to pass. If you do an interview, be passionate and have two to three keySuperficial Radiation for Keloids: SRT-100 in Practice
https://practicaldermatology.com/topics/skin-cancer-photoprotection/superficial-radiation-for-keloids-srt-100-in-practice/19040/Keloids are common. Certain patients, especially patients of color, are more prone to the development of keloids in certain locations, especially areas such as the chest, back, and other areas. Most studies that show that keloids can occur in up to 90 percent of cases when they're excised. The use oPart 3: New Developments in Biologics
https://practicaldermatology.com/topics/psoriasis/part-3-new-developments-in-biologics/18965/In this edition of Derm Insider, host Neal Bhatia, MD tackles the evolving systemic treatment landscape for psoriasis with guests Alice Gottlieb, MD, Harold Farber, MD, and James Ulery, MD. In Part III, they discuss new developments in biologic therapy.Bellafill Fills a Niche; Soolantra Targets Rosacea
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-bellafill-fills-a-niche-soolantra-targets-rosacea-/18995/In this edition of DermWireTV from the editors of Practical Dermatology® magazine, a look at the approval of Bellafill (Suneva) to treat acne scars and Soolantra (Ivermectin 1%, Galderma) to treat rosacea. Plus, Benzac (Galderma) is now available OTC to treat acne, and Opdivo (Bristol-Myers Squibb)Innovations in Injectable Therapies
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/innovations-in-injectable-therapies/19089/From filling to volumizing, Julius Few, MD, FACS talks about evolving approaches to injectables and discusses new fillers, like Voluma.Utilizing different Social Media Platforms for any practice
https://practicaldermatology.com/topics/practice-management/utilizing-different-social-media-platforms-for-any-practice/19094/Social Media allows for a whole new stepping stone when implementing the various forms into your marketing efforts. This webinar discusses the different social media platforms available and how to utilize them in your social media marketing efforts to it's fullest capacity. When implemented and usedAttendees describe Cosmetic Surgery Forum
https://practicaldermatology.com/topics/practice-management/attendees-describe-cosmetic-surgery-forum/19179/Cosmetic Surgery Forum is a discussion-based symposium for dermatology and skin care professionals from across the country. Watch this video of attendees who describe their experiences and the knowledge they took away from the conference. For more information, visit www.cosmeticsurgeryforum.comThe Big Idea: Jeanine Downie, MD on Hiring Decisions
https://practicaldermatology.com/topics/practice-management/the-big-idea-jeanine-downie-md-on-hiring-decisions/19277/Dr. Downie discusses the important considerations in hiring, including how to spot the best candidates and ensure a top-notch patient experience. Featured in "What's the Big Idea"IDAS, LBO Laser System by Quantel Derma
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/idas-lbo-laser-system-by-quantel-derma/19373/IDAS by Quantel Derma - Green Light for Mobile Power. IDAS is the powerful LBO laser system with 532 nm wavelength for vascular indications such as rosacea or telangiectasia and pigmented skin changes. Its 8 watt power make treatments very effective. Due to its robust technology, IDAS has an officia